Eurofins Scientific SE's Total Liabilities for the quarter that ended in Dec. 2025 was $7,504 Mil.
Eurofins Scientific SE's quarterly Total Liabilities
increased
from Dec. 2024 ($5,762.93 Mil) to Jun. 2025 ($6,821.68 Mil) and
increased
from Jun. 2025 ($6,821.68 Mil) to Dec. 2025 ($7,504.33 Mil).
Eurofins Scientific SE's annual Total Liabilities
declined
from Dec. 2023 ($6,271.76 Mil) to Dec. 2024 ($5,762.93 Mil) but then
increased
from Dec. 2024 ($5,762.93 Mil) to Dec. 2025 ($7,504.33 Mil).
Eurofins Scientific SE Total Liabilities Related Terms
Eurofins Scientific SE Total Liabilities Historical Data
* Premium members only.
The historical data trend for Eurofins Scientific SE's Total Liabilities can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Eurofins Scientific SE Total Liabilities Calculation
Total Liabilities are the liabilities that the company has to pay others. It is a part of the balance sheet of a company that shareholders do not own, and would be obligated to pay back if the company liquidated.
Eurofins Scientific SE's Total Liabilities for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Eurofins Scientific SE (ERFSF) has a Total Liabilities of $7,504 Mil as of Dec. 2025. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Eurofins Scientific SE and its competitors.
Is Eurofins Scientific SE's Total Liabilities too high?
Eurofins Scientific SE's current Total Liabilities is $7,504 Mil. Overall, Eurofins Scientific SE has a GF Score™ of 79/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Eurofins Scientific SE's Total Liabilities compare to TMO and DHR?
Eurofins Scientific SE's Total Liabilities of $7,504 Mil can be compared against companies in the Medical Diagnostics & Research industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Total Liabilities for a Medical Diagnostics & Research company?
A good Total Liabilities depends on the Medical Diagnostics & Research industry context. However, Total Liabilities should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Total Liabilities mean?
A high Total Liabilities can signal that a stock is expensive relative to its fundamentals. The total amount of liabilities as recorded on a company's balance sheet. View historical data for Eurofins Scientific SE and its competitors. Eurofins Scientific SE's current Total Liabilities is $7,504 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Eurofins Scientific SE stock overvalued right now?
Based on GuruFocus' analysis, Eurofins Scientific SE (ERFSF) is currently considered Fairly Valued. The stock's GF Value™ is $75.93, compared to a current price of $79.77 — trading 5.1% above its estimated fair value. The current Total Liabilities is $7,504 Mil. Eurofins Scientific SE's overall GF Score™ is 79/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Total Liabilities calculated?
Total Liabilities is calculated from a company's financial statements. For Eurofins Scientific SE (ERFSF), the current Total Liabilities is $7,504 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Eurofins Scientific SE (ERFSF) Overvalued in 2026?
Based on GuruFocus' analysis, Eurofins Scientific SE stock appears to be overvalued.
The current stock price of $79.77 is trading 5.1% above its estimated GF Value™ of $75.93.
GuruFocus considers Eurofins Scientific SE to be Fairly Valued.
Key valuation signals for ERFSF:
Total Liabilities: $7,504 Mil
GF Value™: $75.93 vs. price of $79.77 (5.1% above fair value)
No single metric tells the full story. See the ERFSF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Eurofins, headquartered in Luxembourg, is a decentralized network of life sciences companies that provide various analytical tests and laboratory services. These include tests to evaluate the safety, identity, composition, authenticity, purity, origin, and traceability of various biological substances and products. Eurofins operates over 950 laboratories in 61 countries. Its revenue from Europe, North America, and the rest of the world contributes approximately 50%, 40%, and 10% of total revenue, respectively. Its areas of business activity are food, feed, and environmental testing ("life"), biopharmaceutical services, diagnostic services and products, and consumer and technology products testing, which contribute approximately 40%, 30%, 20%, and 10% respectively.
79GF Score
Get the complete analysis for ERFSF
Total Liabilities is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ERFSF has been successfully added to your 
